ATTRACT is an Austrian 🇦🇹 Clinical Research Group dedicated to improving therapy for glioblastoma, the most aggressive brain tumor in adults 🧠💊
https://tinyurl.com/attract-crg
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm